Prognostic value of p16INK4a overexpression in penile cancer

被引:6
作者
Pereira-Lourenco, Mario [1 ]
Vieira e Brito, Duarte [1 ]
Eliseu, Miguel [2 ]
Castelo-Branco, Noemia [3 ]
Peralta, Joao Pedro [1 ]
Godinho, Ricardo [1 ]
Conceicao, Paulo [1 ]
Reis, Mario [1 ]
Rabaca, Carlos [1 ]
Sismeiro, Amilcar [1 ]
机构
[1] Portuguese Inst Oncol Coimbra, Urol Dept, Rua Maria Bourbon Bobone,N57, Coimbra, Portugal
[2] Coimbra Hosp Univ Ctr, Urol & Kidney Transplant Dept, Coimbra, Portugal
[3] Portuguese Inst Oncol Coimbra, Pathol Dept, Coimbra, Portugal
关键词
Penile cancer; HPV; p16; Prognosis; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS DNA; RIO-DE-JANEIRO; HPV; EXPRESSION; RISK; CLASSIFICATION; PREVALENCE; INFECTION; PSORALEN;
D O I
10.4081/aiua.2020.1.11
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Penile cancer is rare, accounting for less than 1% of all male cancers in industrialized countries. It is most common in areas of high prevalence of HPV, being a third of cases attributed to the carcinogenic effect of HPV. Tumour cells infected with HPV overexpress p16(INK4a), as such p16(INK4a) has been used as a surrogate of HPV infections. Objective: To evaluate the prognostic factor of p16(INK4a) over-expression in penile cancer. Methods: Retrospective analysis of patients diagnosed with penile cancer, submitted to surgery in a Portuguese Ontological Institution in the last 20 years (n = 35). Histological review of surgical pieces and immunohistochernical ident ifi cation of p16(INK4a). Relation between p16INK4a and the following factors were studied: age, histological subtype, tumour dimensions, grade, TNM stage, perineural invasion, perivascular invasion, disease free survival (DFS) and cancer specific. survival (CSS). Results: p16(INK4a) was positive in 8 patients (22.9%). Identification of p16(INK4a) did not correlate with none of the histopathological factors. In this work weidentified a better DFS and CSS in patients positive for p16(INK4a) (DFS at 36 months was 100.0% vs. 66.7%; CSS at 36 months was 100.0% vs. 70.4%), although without statistical significance (p > 0.05). In multivariate analysis of histopathological factors studied, only N staging correlated with DFS and CSS (p = 0.017 and p = 0.014, respectively). Discussion: the percentage of cases positive for p16(INK4a) is smaller than the one found in literature, which can suggest a less relevant part of IIPV infection in the oncogenesis of penile cancer in the studied population. Identification of p16(INK4a) did not relate with other clinicopathological factors. Tendency for a more favourable prognosis in patients with p16(INK4a) agrees with results found in literature. The most relevant factor for prognosis is nodal staging. Conclusions: penile cancer positive for p16INK4a shows a trend for better survival, although the most relevant factor is nodal staging.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 47 条
[1]   High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis [J].
Afonso, Larissa A. ;
Cordeiro, Thaissa I. ;
Carestiato, Fernanda N. ;
Ornellas, Antonio Augusto ;
Alves, Gilda ;
Cavalcanti, Silvia M. B. .
JOURNAL OF UROLOGY, 2016, 195 (06) :1784-1789
[2]   Human papillomavirus, Epstein-Barr virus, and methylation status of p16ink4a in penile cancer [J].
Afonso, Larissa Alves ;
Carestiato, Fernanda Nahoum ;
Ornellas, Antonio Augusto ;
Ornellas, Paulo ;
Rocha, Willker Menezes ;
Cordeiro, Thaissa Isaias ;
Lisboa, Daniela Ceperuelo ;
Alves, Gilda Brown ;
Baeta Cavalcanti, Silvia Maria .
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (10) :1837-1843
[3]   Role of Human Papillomavirus in Penile Carcinomas Worldwide [J].
Alemany, Laia ;
Cubilla, Antonio ;
Halec, Gordana ;
Kasamatsu, Elena ;
Quiros, Beatriz ;
Masferrer, Emili ;
Tous, Sara ;
Lloveras, Belen ;
Hernandez-Suarez, Gustavo ;
Lonsdale, Ray ;
Tinoco, Leopoldo ;
Alejo, Maria ;
Alvarado-Cabrero, Isabel ;
Laco, Jan ;
Guimera, Nuria ;
Poblet, Enrique ;
Lombardi, Luis E. ;
Bergeron, Christine ;
Clavero, Omar ;
Shin, Hai-Rim ;
Ferrera, Annabelle ;
Felix, Ana ;
Germar, Julieta ;
Mandys, Vaclav ;
Clavel, Christine ;
Tzardi, Maria ;
Pons, Luis E. ;
Wain, Vincent ;
Cruz, Eugenia ;
Molina, Carla ;
Mota, Jose D. ;
Jach, Robert ;
Velasco, Julio ;
Carrilho, Carla ;
Lopez-Revilla, Ruben ;
Goodman, Marc T. ;
Quint, Wim G. ;
Castellsague, Xavier ;
Bravo, Ignacio ;
Pawlita, Michael ;
Munoz, Nubia ;
Bosch, F. Xavier ;
de Sanjose, Silvia .
EUROPEAN UROLOGY, 2016, 69 (05) :953-961
[4]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[5]  
[Anonymous], 2002, IARC SCI PUBL, VVIII, P1
[6]   Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review [J].
Archier, E. ;
Devaux, S. ;
Castela, E. ;
Gallini, A. ;
Aubin, F. ;
Le Maitre, M. ;
Aractingi, S. ;
Bachelez, H. ;
Cribier, B. ;
Joly, P. ;
Jullien, D. ;
Misery, L. ;
Paul, C. ;
Ortonne, J-P ;
Richard, M-A .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 :22-31
[7]   Systematic review of human papillomavirus prevalence in invasive penile cancer [J].
Backes, Danielle M. ;
Kurman, Robert J. ;
Pimenta, Jeanne M. ;
Smith, Jennifer S. .
CANCER CAUSES & CONTROL, 2009, 20 (04) :449-457
[8]   Incidence trends in primary malignant penile cancer [J].
Barnholtz-Sloan, Jill S. ;
Maldonado, John L. ;
Pow-Sang, Julio ;
Guiliano, Anna R. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :361-367
[9]   Clinical and Pathologic Factors of Prognostic Significance in Penile Squamous Cell Carcinoma in a North American Population [J].
Bethune, Gillian ;
Campbell, Jeffrey ;
Rocker, Adam ;
Bell, David ;
Rendon, Ricardo ;
Merrimen, Jennifer .
UROLOGY, 2012, 79 (05) :1092-1097
[10]  
Bezerra ALR, 2001, CANCER, V91, P2315, DOI 10.1002/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO